Ms. Iris Bincovich reports

VALITIC SURPASSES 2 MILLION TRUSTED CUSTOMERS, MARKING A MAJOR MILESTONE IN ITS CONSUMER WELLNESS GROWTH

The flagship skin care brand, Valitic, of B.I. Sky Global Ltd., the consumer wellness subsidiary of Innocan Pharma Corp., has surpassed two million trusted customers, marking a significant milestone in the company's continued expansion in the beauty and personal care market.

Built on a commitment to developing innovative, consumer-focused skin care products, Valitic has experienced strong growth across leading e-commerce platforms, earning the confidence of millions of customers through high-quality formulations and consistent product performance.

"This a remarkable achievement and validates our strategy of combining innovative product development with data-driven digital marketing," said Roni Kamhi, chief executive officer of B.I. Sky Global. "Consumer trust is earned one customer at a time. This milestone reflects the quality of our products, the dedication of our team, and our relentless focus on understanding and meeting evolving consumer needs."

Iris Bincovich, chief executive officer of Innocan, added: "This milestone demonstrates the successful execution of our growth strategy. We believe this achievement marks an important step toward creating sustainable long-term value for our shareholders.

About Innocan Pharma Corp.

Innocan is an innovator in the pharmaceutical and wellness sectors. In the pharmaceutical sector, Innocan developed a cannabidiol-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of synthetic cannabidiol for non-opioid pain management. In the wellness sector, Innocan develops and markets a wide portfolio of high performance self-care and beauty products to promote a healthier lifestyle. Under this segment, Innocan carries on business through its 60-per-cent-owned subsidiary, B.I. Sky Global, which focuses on advanced, targeted on-line sales.

We seek Safe Harbor.